Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Martin Rimmer

Effects of the SRC Kinase Inhibitor Saracatinib (AZD0530) on Bone Turnover in Healthy Men: A Randomized, Double-Blind, Placebo-Controlled, Multiple-Ascending-Dose Phase I Trial

Journal of Bone and Mineral Research

English

Related publications

Etanercept in Alzheimer Disease: A Randomized, Placebo-Controlled, Double-Blind, Phase 2 Trial

Neurology

2015

English

Effects of Oral Methamphetamine on Cocaine Use: A Randomized, Double-Blind, Placebo-Controlled Trial

Drug and Alcohol Dependence

English

A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Duloxetine in Japanese Fibromyalgia Patients

Arthritis Research and Therapy

English

Comparison of the Effects of Ketamine and Memantine on Prolactin and Cortisol Release in Men a Randomized, Double-Blind, Placebo-Controlled Trial

Neuropsychopharmacology

English

A Phase I, Placebo-Controlled, Randomized, Double-Blind, Single Ascending Dose-Ranging Study to Evaluate the Safety and Tolerability of a Novel Biophysical Bronchodilator (S-1226) Administered by Nebulization in Healthy Volunteers

English

Randomized, Double-Blind, Placebo-Controlled Trial on Symptomatic Effects of Coenzyme Q10 in Parkinson Disease

Archives of Neurology

2007

English

Randomized, Double-Blind, Placebo-Controlled Trial of Saw Palmetto in Men With Lower Urinary Tract Symptoms

Urology

2001

English

Estimating the Probability of Tolerating Each Challenge Dose of Peanut Protein at Exit Double-Blind, Placebo-Controlled Food Challenge: Results From a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (PALISADE) of AR101

Journal of Allergy and Clinical Immunology

Allergy

Immunology

2019

English

Fluoxetine for Depression in Diabetes: A Randomized Double-Blind Placebo-Controlled Trial

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Martin Rimmer

Effects of the SRC Kinase Inhibitor Saracatinib (AZD0530) on Bone Turnover in Healthy Men: A Randomized, Double-Blind, Placebo-Controlled, Multiple-Ascending-Dose Phase I Trial

Related publications

Etanercept in Alzheimer Disease: A Randomized, Placebo-Controlled, Double-Blind, Phase 2 Trial

Effects of Oral Methamphetamine on Cocaine Use: A Randomized, Double-Blind, Placebo-Controlled Trial

A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Duloxetine in Japanese Fibromyalgia Patients

Comparison of the Effects of Ketamine and Memantine on Prolactin and Cortisol Release in Men a Randomized, Double-Blind, Placebo-Controlled Trial

A Phase I, Placebo-Controlled, Randomized, Double-Blind, Single Ascending Dose-Ranging Study to Evaluate the Safety and Tolerability of a Novel Biophysical Bronchodilator (S-1226) Administered by Nebulization in Healthy Volunteers

Randomized, Double-Blind, Placebo-Controlled Trial on Symptomatic Effects of Coenzyme Q10 in Parkinson Disease

Randomized, Double-Blind, Placebo-Controlled Trial of Saw Palmetto in Men With Lower Urinary Tract Symptoms

Estimating the Probability of Tolerating Each Challenge Dose of Peanut Protein at Exit Double-Blind, Placebo-Controlled Food Challenge: Results From a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (PALISADE) of AR101

Fluoxetine for Depression in Diabetes: A Randomized Double-Blind Placebo-Controlled Trial